301 related articles for article (PubMed ID: 35351808)
1. Smoking, alcohol consumption and disease-specific outcomes in rheumatic and musculoskeletal diseases (RMDs): systematic reviews informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
Wieczorek M; Gwinnutt JM; Ransay-Colle M; Balanescu A; Bischoff-Ferrari H; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm TA; Walker-Bone K; Welling J; Zlatkovic-Svenda M; Verstappen SM; Guillemin F
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35351808
[TBL] [Abstract][Full Text] [Related]
2. Effects of diet on the outcomes of rheumatic and musculoskeletal diseases (RMDs): systematic review and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
Gwinnutt JM; Wieczorek M; Rodríguez-Carrio J; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda M; Guillemin F; Verstappen SMM
RMD Open; 2022 Jun; 8(2):. PubMed ID: 35654458
[TBL] [Abstract][Full Text] [Related]
3. Effects of physical exercise and body weight on disease-specific outcomes of people with rheumatic and musculoskeletal diseases (RMDs): systematic reviews and meta-analyses informing the 2021 EULAR recommendations for lifestyle improvements in people with RMDs.
Gwinnutt JM; Wieczorek M; Cavalli G; Balanescu A; Bischoff-Ferrari HA; Boonen A; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM
RMD Open; 2022 Mar; 8(1):. PubMed ID: 35361692
[TBL] [Abstract][Full Text] [Related]
4. 2021 EULAR recommendations regarding lifestyle behaviours and work participation to prevent progression of rheumatic and musculoskeletal diseases.
Gwinnutt JM; Wieczorek M; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Putrik P; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda MI; Guillemin F; Verstappen SMM
Ann Rheum Dis; 2023 Jan; 82(1):48-56. PubMed ID: 35260387
[TBL] [Abstract][Full Text] [Related]
5. Association of vocational interventions and work-related factors with disease and work outcomes in people with RMDs: A systematic review.
Wieczorek M; Verstappen SM; Putrik P; Gwinnutt JM; Balanescu A; Bischoff-Ferrari HA; Boonen A; Cavalli G; de Souza S; de Thurah A; Dorner TE; Moe RH; Rodríguez-Carrio J; Silva-Fernández L; Stamm T; Walker-Bone K; Welling J; Zlatković-Švenda M; Guillemin F
Semin Arthritis Rheum; 2023 Feb; 58():152135. PubMed ID: 36434893
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of non-pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Santos EJF; Farisogullari B; Dures E; Geenen R; Machado PM;
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37604639
[TBL] [Abstract][Full Text] [Related]
7. Developing a framework for the implementation of recommendations for lifestyle factors for people with RMDs across Europe: assessment of current materials and implementation needs.
Rodríguez-Carrio J; Cavalli G; Gwinnutt J; Wieczorek M; Guillemin F; Verstappen SMM
RMD Open; 2023 Aug; 9(3):. PubMed ID: 37652556
[TBL] [Abstract][Full Text] [Related]
8. Living with foot and ankle disorders in rheumatic and musculoskeletal diseases: A systematic review of qualitative studies to inform the work of the OMERACT Foot and Ankle Working Group.
Chapman LS; Flurey CA; Redmond AC; Richards P; Hofstetter C; Tapster B; Emmel J; Helliwell PS; Menz HB; Hannan MT; Shea B; Siddle HJ
Semin Arthritis Rheum; 2023 Aug; 61():152212. PubMed ID: 37207417
[TBL] [Abstract][Full Text] [Related]
9. Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider.
Rodríguez-Carrio J; Burska A; Conaghan PG; Dik WA; Biesen R; Eloranta ML; Cavalli G; Visser M; Boumpas DT; Bertsias G; Wahren-Herlenius M; Rehwinkel J; Frémond ML; Crow MK; Ronnblom L; Vital E; Versnel M
RMD Open; 2023 Mar; 9(1):. PubMed ID: 36882218
[TBL] [Abstract][Full Text] [Related]
10. Assessment of impact of the COVID-19 pandemic from the perspective of patients with rheumatic and musculoskeletal diseases in Europe: results from the REUMAVID study (phase 1).
Garrido-Cumbrera M; Marzo-Ortega H; Christen L; Plazuelo-Ramos P; Webb D; Jacklin C; Irwin S; Grange L; Makri S; Frazão Mateus E; Mingolla S; Antonopoulou K; Sanz-Gómez S; Correa-Fernández J; Carmona L; Navarro-Compán V
RMD Open; 2021 Apr; 7(1):. PubMed ID: 33827969
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey.
Branco JC; Rodrigues AM; Gouveia N; Eusébio M; Ramiro S; Machado PM; da Costa LP; Mourão AF; Silva I; Laires P; Sepriano A; Araújo F; Gonçalves S; Coelho PS; Tavares V; Cerol J; Mendes JM; Carmona L; Canhão H;
RMD Open; 2016; 2(1):e000166. PubMed ID: 26848402
[TBL] [Abstract][Full Text] [Related]
12. Trends for opioid prescribing and the impact of the COVID-19 pandemic in patients with rheumatic and musculoskeletal diseases between 2006 and 2021.
Huang YT; Jenkins DA; Yimer BB; Benitez-Aurioles J; Peek N; Lunt M; Dixon WG; Jani M
Rheumatology (Oxford); 2024 Apr; 63(4):1093-1103. PubMed ID: 37432340
[TBL] [Abstract][Full Text] [Related]
13. Development and application of a questionnaire to assess patient beliefs in rheumatoid arthritis and axial spondyloarthritis.
Gossec L; Berenbaum F; Chauvin P; Hudry C; Cukierman G; de Chalus T; Dreuillet C; Saulot V; Tong S; Russo-Marie F; Joubert JM; Saraux A
Clin Rheumatol; 2018 Oct; 37(10):2649-2657. PubMed ID: 29948351
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of pharmacological interventions: a systematic review informing the 2023 EULAR recommendations for the management of fatigue in people with inflammatory rheumatic and musculoskeletal diseases.
Farisogullari B; Santos EJF; Dures E; Geenen R; Machado PM; ;
RMD Open; 2023 Dec; 9(4):. PubMed ID: 38056919
[TBL] [Abstract][Full Text] [Related]
15. Current status of use of big data and artificial intelligence in RMDs: a systematic literature review informing EULAR recommendations.
Kedra J; Radstake T; Pandit A; Baraliakos X; Berenbaum F; Finckh A; Fautrel B; Stamm TA; Gomez-Cabrero D; Pristipino C; Choquet R; Servy H; Stones S; Burmester G; Gossec L
RMD Open; 2019; 5(2):e001004. PubMed ID: 31413871
[TBL] [Abstract][Full Text] [Related]
16. Physicians' vs patients' global assessments of disease activity in rheumatology and musculoskeletal trials: A meta-research project with focus on reasons for discrepancies.
Lynæs C; Lynæs M; Simon LS; Tugwell P; D'Agostino MA; Strand V; Juhl CB; Nielsen SM; De Witt M; Beaton D; Maxwell LJ; Meara AS; Christensen R;
Semin Arthritis Rheum; 2022 Oct; 56():152074. PubMed ID: 35921746
[TBL] [Abstract][Full Text] [Related]
17. Nursing interventions for patients with rheumatic and musculoskeletal diseases on biological therapies: a systematic literature review.
Melis MR; El Aoufy K; Bambi S; Bruni C; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Rasero L
Clin Rheumatol; 2023 Jun; 42(6):1521-1535. PubMed ID: 36801986
[TBL] [Abstract][Full Text] [Related]
18. Smoking and alcohol consumption are associated with peripheral musculoskeletal involvement in patients with spondyloarthritis (including psoriatic arthritis). Results from the ASAS-PerSpA study.
Ladehesa-Pineda ML; Ortega-Castro R; Puche-Larrubia MÁ; Granados REM; Dougados M; Collantes-Estévez E; López-Medina C
Semin Arthritis Rheum; 2023 Feb; 58():152146. PubMed ID: 36516482
[TBL] [Abstract][Full Text] [Related]
19. EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome.
Drosos GC; Vedder D; Houben E; Boekel L; Atzeni F; Badreh S; Boumpas DT; Brodin N; Bruce IN; González-Gay MÁ; Jacobsen S; Kerekes G; Marchiori F; Mukhtyar C; Ramos-Casals M; Sattar N; Schreiber K; Sciascia S; Svenungsson E; Szekanecz Z; Tausche AK; Tyndall A; van Halm V; Voskuyl A; Macfarlane GJ; Ward MM; Nurmohamed MT; Tektonidou MG
Ann Rheum Dis; 2022 Jun; 81(6):768-779. PubMed ID: 35110331
[TBL] [Abstract][Full Text] [Related]
20. Elucidating the environmental risk factors for rheumatic diseases: An umbrella review of meta-analyses.
Belbasis L; Dosis V; Evangelou E
Int J Rheum Dis; 2018 Aug; 21(8):1514-1524. PubMed ID: 30146746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
